- Home
- IMRN vs AQMS Comparison
IMRN vs AQMS Comparison
Compare IMRN & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- AQMS
- Stock Information
- Founded
- IMRN 1994
- AQMS 2014
- Country
- IMRN Australia
- AQMS United States
- Employees
- IMRN N/A
- AQMS N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- IMRN Health Care
- AQMS Industrials
- Exchange
- IMRN Nasdaq
- AQMS Nasdaq
- Market Cap
- IMRN 15.0M
- AQMS 17.8M
- IPO Year
- IMRN N/A
- AQMS 2015
- Fundamental
- Price
- IMRN $2.15
- AQMS $1.98
- Analyst Decision
- IMRN Strong Buy
- AQMS Strong Buy
- Analyst Count
- IMRN 1
- AQMS 2
- Target Price
- IMRN $5.00
- AQMS $30.00
- AVG Volume (30 Days)
- IMRN 21.6K
- AQMS 371.2K
- Earning Date
- IMRN 02-26-2025
- AQMS 11-14-2024
- Dividend Yield
- IMRN N/A
- AQMS N/A
- EPS Growth
- IMRN N/A
- AQMS N/A
- EPS
- IMRN N/A
- AQMS N/A
- Revenue
- IMRN $3,271,194.00
- AQMS N/A
- Revenue This Year
- IMRN N/A
- AQMS N/A
- Revenue Next Year
- IMRN N/A
- AQMS N/A
- P/E Ratio
- IMRN N/A
- AQMS N/A
- Revenue Growth
- IMRN 171.67
- AQMS 525.00
- 52 Week Low
- IMRN $1.59
- AQMS $1.33
- 52 Week High
- IMRN $5.96
- AQMS $14.14
- Technical
- Relative Strength Index (RSI)
- IMRN 56.18
- AQMS 41.02
- Support Level
- IMRN $1.85
- AQMS $1.92
- Resistance Level
- IMRN $2.20
- AQMS $2.14
- Average True Range (ATR)
- IMRN 0.22
- AQMS 0.28
- MACD
- IMRN 0.01
- AQMS -0.05
- Stochastic Oscillator
- IMRN 57.47
- AQMS 6.32
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.